Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wesley L McKeithan

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Opinion in Pharmacology|August 7, 2018
Will iPSC-cardiomyocytes revolutionize the discovery of drugs for heart disease?Arne An Bruyneel, Wesley L McKeithan, Dries Am Feyen, et al.
Current Cardiology Reports|May 27, 2018
Using iPSC Models to Probe Regulation of Cardiac Ion Channel FunctionArne A N Bruyneel, Wesley L McKeithan, Dries A M Feyen, et al.
Current Protocols in Stem Cell Biology|November 17, 2012
Serum-free generation of multipotent mesoderm (Kdr+) progenitor cells in mouse embryonic stem cells for functional genomics screeningWesley L McKeithan, Alexandre R Colas, Paul J Bushway, et al.
Pharmacology Research & Perspectives|July 30, 2021
Human-induced pluripotent stem cell-derived cardiomyocytes: Cardiovascular properties and metabolism and pharmacokinetics of deuterated mexiletine analogsJorge Gomez-Galeno, Karl Okolotowicz, Mark Johnson, et al.
Science (New York, N.Y.)|October 16, 2020
Engineering synthetic morphogen systems that can program multicellular patterningSatoshi Toda, Wesley L McKeithan, Teemu J Hakkinen, et al.
Genes & Development|November 16, 2012
Whole-genome microRNA screening identifies let-7 and mir-18 as regulators of germ layer formation during early embryogenesisAlexandre R Colas, Wesley L McKeithan, Thomas J Cunningham, et al.
Nature Protocols|November 11, 2018
Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicityArun Sharma, Wesley L McKeithan, Ricardo Serrano, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2021
Human iPSC-derived cardiomyocytes and pyridyl-phenyl mexiletine analogsMark Johnson, Jorge Gomez-Galeno, Daniel Ryan, et al.
Journal of Medicinal Chemistry|May 4, 2021
Antiarrhythmic Hit to Lead Refinement in a Dish Using Patient-Derived iPSC CardiomyocytesJohn R Cashman, Daniel Ryan, Wesley L McKeithan, et al.
Frontiers in Physiology|October 28, 2017
An Automated Platform for Assessment of Congenital and Drug-Induced Arrhythmia with hiPSC-Derived CardiomyocytesWesley L McKeithan, Alex Savchenko, Michael S Yu, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Opinion in Pharmacology|August 7, 2018
Will iPSC-cardiomyocytes revolutionize the discovery of drugs for heart disease?Arne An Bruyneel, Wesley L McKeithan, Dries Am Feyen, et al.
Current Cardiology Reports|May 27, 2018
Using iPSC Models to Probe Regulation of Cardiac Ion Channel FunctionArne A N Bruyneel, Wesley L McKeithan, Dries A M Feyen, et al.
Current Protocols in Stem Cell Biology|November 17, 2012
Serum-free generation of multipotent mesoderm (Kdr+) progenitor cells in mouse embryonic stem cells for functional genomics screeningWesley L McKeithan, Alexandre R Colas, Paul J Bushway, et al.
Pharmacology Research & Perspectives|July 30, 2021
Human-induced pluripotent stem cell-derived cardiomyocytes: Cardiovascular properties and metabolism and pharmacokinetics of deuterated mexiletine analogsJorge Gomez-Galeno, Karl Okolotowicz, Mark Johnson, et al.
Science (New York, N.Y.)|October 16, 2020
Engineering synthetic morphogen systems that can program multicellular patterningSatoshi Toda, Wesley L McKeithan, Teemu J Hakkinen, et al.
Genes & Development|November 16, 2012
Whole-genome microRNA screening identifies let-7 and mir-18 as regulators of germ layer formation during early embryogenesisAlexandre R Colas, Wesley L McKeithan, Thomas J Cunningham, et al.
Nature Protocols|November 11, 2018
Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicityArun Sharma, Wesley L McKeithan, Ricardo Serrano, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2021
Human iPSC-derived cardiomyocytes and pyridyl-phenyl mexiletine analogsMark Johnson, Jorge Gomez-Galeno, Daniel Ryan, et al.
Journal of Medicinal Chemistry|May 4, 2021
Antiarrhythmic Hit to Lead Refinement in a Dish Using Patient-Derived iPSC CardiomyocytesJohn R Cashman, Daniel Ryan, Wesley L McKeithan, et al.
Frontiers in Physiology|October 28, 2017
An Automated Platform for Assessment of Congenital and Drug-Induced Arrhythmia with hiPSC-Derived CardiomyocytesWesley L McKeithan, Alex Savchenko, Michael S Yu, et al.
Pageof 2